Gene: DTWD2
Official Full Name: DTW domain containing 2provided by HGNC
Gene Summary: Enables tRNA-uridine aminocarboxypropyltransferase activity. Involved in RNA glycosylation and tRNA modification. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18152 | DTWD2 Knockout cell line (HeLa) | Human | DTWD2 | 1:3~1:6 | Negative | Online Inquiry |
KO18153 | DTWD2 Knockout cell line (HCT 116) | Human | DTWD2 | 1:2~1:4 | Negative | Online Inquiry |
KO18154 | DTWD2 Knockout cell line (HEK293) | Human | DTWD2 | 1:3~1:6 | Negative | Online Inquiry |
KO18155 | DTWD2 Knockout cell line (A549) | Human | DTWD2 | 1:3~1:4 | Negative | Online Inquiry |
DTWD2 Gene Knockout Cell Lines are sophisticated, genetically modified cell lines designed to specifically silence the DTWD2 gene, providing researchers with a powerful tool for functional genomics and cellular biology studies. DTWD2, or "diverse transcript variation and degradation 2," is implicated in various cellular processes, including cell division and apoptosis. By creating knockout variants, these cell lines allow for the investigation of the gene's role in different biological contexts, elucidating regulatory mechanisms and pathways modulated by DTWD2.
The mechanism behind DTWD2 gene knockout involves the precise alteration of the genetic sequence, often utilizing CRISPR-Cas9 technology or other gene-editing techniques, ensuring a stable and reproducible elimination of gene expression. This enables researchers to cultivate and analyze cell lines devoid of DTWD2, facilitating studies on gene function, cell signaling, and responses to therapeutic agents. Such insights are pivotal in understanding diseases where DTWD2 might contribute to pathogenesis, thus providing a platform for innovative therapeutic target identification.
The scientific importance of DTWD2 Gene Knockout Cell Lines extends across various research domains, including cancer biology, developmental biology, and pharmacology. Their applications in clinical settings also allow for better insights into the mechanisms underlying drug resistance and tumorigenesis. Moreover, compared to conventional methods that may involve non-targeted approaches, these knockout lines offer specificity and reliability, reducing experimental variability.
What sets DTWD2 Gene Knockout Cell Lines apart from alternative products is their robust characterization and validation, ensuring that researchers can achieve reproducible results. Additionally, they come with comprehensive user support, complete with guidelines for experimental design and troubleshooting, making them invaluable assets in any laboratory.
For researchers and clinicians seeking to deepen their understanding of cellular mechanisms or develop new therapeutic strategies, DTWD2 Gene Knockout Cell Lines are essential. Their unique capabilities for targeted gene disruption are unmatched in providing critical insights into gene function and disease pathology.
At our company, we boast a wealth of expertise in the development of high-quality biological products, ensuring that our offerings, including DTWD2 Gene Knockout Cell Lines, meet the rigorous standards of current scientific research and advance your innovative projects.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.